Cargando…

Efficacy and safety of tocilizumab in COVID-19 patients

In this retrospective study we assessed the efficacy and safety of tocilizumab in patients with critical or severe coronavirus disease 2019 (COVID-19). We enrolled 181 patients admitted to Huoshenshan Hospital (Wuhan, China) with confirmed COVID-19 between January 2020 and February 2020. Ninety-two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Kai-Lian, Xu, Ying, Guo, Yu-Feng, Diao, Le, Kong, Xiang-Yu, Wan, Xiao-Jian, Zhao, Feng, Ning, Fang-Zheng, Wang, Li-Bing, Qiao, Fan, Zhao, Jiang-Man, Zhou, Jia-Huan, Zhong, Yue-Qian, Wu, Shou-Xin, Chen, Yi, Jin, Gang, Dong, Yu-Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732317/ https://www.ncbi.nlm.nih.gov/pubmed/33031060 http://dx.doi.org/10.18632/aging.103988

Ejemplares similares

Prediction of the Number of Patients Infected with COVID-19 Based on Rolling Grey Verhulst Models
por: Zhao, Yu-Feng, et al.
Publicado: (2020)

Integrated safety in tocilizumab clinical trials
por: Schiff, Michael H, et al.
Publicado: (2011)

A phase I study comparing the pharmacokinetics and safety of HS628 (tocilizumab biosimilar) and reference tocilizumab in healthy male subjects
por: Qian, Hongjie, et al.
Publicado: (2023)

Therapeutic Effect of Tocilizumab on Inhibiting Cytokine Release Syndrome in Severe Coronavirus Disease 2019 Patients
por: Xu, Lengnan, et al.
Publicado: (2022)

Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
por: Ogata, Atsushi, et al.
Publicado: (2012)

Pilot study of tocilizumab monotherapy for active chronic periaortitis
por: Wang, Anqi, et al.
Publicado: (2023)

Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis
por: Luo, Lili, et al.
Publicado: (2022)

Efficacy and safety of stellate ganglion block in chronic ulcerative colitis
por: Zhao, Hong-Ying, et al.
Publicado: (2017)

Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)
por: Burmester, Gerd R, et al.
Publicado: (2016)

Assessment of the safety and probiotic characteristics of Lactobacillus salivarius CGMCC20700 based on whole-genome sequencing and phenotypic analysis
por: Jiang, Yu-Hang, et al.
Publicado: (2023)

The efficacy and safety of Tocilizumab in adults with refractory systemic onset JIA
por: Deslypere, G, et al.
Publicado: (2011)

Tocilizumab: A Review of Its Safety and Efficacy in Rheumatoid Arthritis
por: Jones, Graeme, et al.
Publicado: (2010)

Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
por: Horneff, G, et al.
Publicado: (2015)

Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
por: Baek, Han Joo, et al.
Publicado: (2019)

Relationship between Tumor Infiltrating Immune Cells and Tumor Metastasis and Its Prognostic Value in Cancer
por: Li, Huan-Xiang, et al.
Publicado: (2022)

Apolipoprotein E gene ε4ε4 is associated with elevated risk of primary open angle glaucoma in Asians: a meta-analysis
por: Wang, Yong, et al.
Publicado: (2014)

Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis
por: Castagné, Benjamin, et al.
Publicado: (2019)

Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis
por: Emery, Paul, et al.
Publicado: (2019)

Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis
por: Temmoku, Jumpei, et al.
Publicado: (2022)

Mitochondrial Function and Reactive Oxygen/Nitrogen Species in Skeletal Muscle
por: Chen, Ming-Ming, et al.
Publicado: (2022)

Tocilizumab in COVID-19 therapy: who benefits, and how?
por: Yang, Chengliang, et al.
Publicado: (2021)

Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis
por: de Boysson, Hubert, et al.
Publicado: (2021)

Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
por: Alexeeva, E, et al.
Publicado: (2011)

Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
por: Nemiche, O, et al.
Publicado: (2011)

Utility and safety of tocilizumab in Takayasu arteritis with severe heart failure and muscle wasting
por: Yano, Toshiyuki, et al.
Publicado: (2019)

Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19
por: Abbasian, Ladan, et al.
Publicado: (2022)

513. Evaluating the safety of baricitinib versus tocilizumab in hospitalized patients with COVID-19
por: Brickel, Kendall, et al.
Publicado: (2023)

Physicochemical and Biological Characterization of the Proposed Biosimilar Tocilizumab
por: Miao, Shiwei, et al.
Publicado: (2017)

Retinal safety and toxicity study of artesunate in vitro and in vivo
por: Lu, Bing-Wen, et al.
Publicado: (2022)

Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report
por: Cai, Sisi, et al.
Publicado: (2019)

Tocilizumab and COVID-19
por: Chaudhry, Dhruva, et al.
Publicado: (2020)

Efficacy and safety of Tongdutiaoshen acupuncture on insomnia in maintenance hemodialysis patients: A randomized clinical trial protocol
por: Wang, Pei, et al.
Publicado: (2023)

In(2)O(3) Nanotower Hydrogen Gas Sensors Based on Both Schottky Junction and Thermoelectronic Emission
por: Zheng, Zhao Qiang, et al.
Publicado: (2015)

Tocilizumab Was Effective in Repairing the Large Geode in a Patient with Rheumatoid Arthritis
por: Izumiyama, Takuya, et al.
Publicado: (2020)

Efficacy and safety of tocilizumab in Behçet’s syndrome with refractory arterial lesions: a single-centre observational cohort study in China
por: Zhong, Hua, et al.
Publicado: (2021)

Association between tocilizumab treatment and clinical outcomes of COVID-19 patients: a systematic review and meta-analysis
por: Peng, Jingwen, et al.
Publicado: (2022)

Development and psychometric assessment of self-reported patient medication safety scale (SR-PMSS)
por: Qin, Ning, et al.
Publicado: (2023)

Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis
por: Evans, Jobie, et al.
Publicado: (2016)

Malignant Peritoneum Mesothelioma with Hepatic Involvement: A Single Institution Experience in 5 Patients and Review of the Literature
por: Su, Shan-shan, et al.
Publicado: (2016)

Effective treatment of severe COVID-19 patients with tocilizumab
por: Xu, Xiaoling, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_78nvhokoh7oesu6po61alpm5hc